|Day Low/High||128.52 / 131.75|
|52 Wk Low/High||113.52 / 174.00|
ChemoCentryx, Jazz Pharmaceuticals, Ionis Pharmaceuticals and Zogenix were among the biotech stock movers in premarket trading Friday.
Jim Cramer looks for domestic stocks he thinks will benefit from lower taxes and deregulation in the Trump era.
Jim Cramer says the future doesn't look healthy for Fitbit, but he's bullish on Xilinx and T-Mobile.
CoLucid Pharmaceuticals saw shares boost 32% ahead of the market open Wednesday.
The negative investor sentiment for health care stocks in 2016 presented a particularly challenging environment to accomplish anything well. Each of these CEOs met the challenge and succeeded.
TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,300 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: CSWC, FNV, INTT, SCHL, VSAT Downgrades: AE, ASH, CNTY, CVV, HCOM, JAZZ, JLL, KND, MAC, MGNX, NS, OLED, OLP, SCSC, SEAS, TGH, XNCR Initiations: ABTX Read on to get TheStreet Quant Ratings' detailed report:
Jazz Pharmaceuticals's third-quarter results missed analysts' projections.
But we could see more volatility in the market.
While the public seized on Mylan's price increases for EpiPens, the story of a common drug industry practice - increasing prices ahead of generics entering the market - got lost.
Jazz Pharmaceuticals (JAZZ) reported lower earnings and revenue for the 2016 second quarter and gave an outlook below Wall Street's expectations.
TheStreet highlights 3 stocks pushing the health care sector higher today.
TheStreet's Adam Feuerstein answers reader questions about biotech stocks.
Jazz Pharma (JAZZ) stock coverage was started with an ‘outperform’ rating and $190 price target at BMO Capital.
U.S. markets ended May on a positive note, despite fears over the likelihood of a summer rate hike by the Federal Reserve that made trading unpredictable.
Stock are on track for a mixed month as escalating fears over the likelihood of a summer rate hike from the Federal Reserve erases gains for the Dow.
Stocks fluctuate Tuesday morning as a big boost in consumer spending in April increases the chances the Federal Reserve will implement another rate hike this summer.
The uptick in the small- and mid-cap space bodes well for future capital appreciation.
Stock futures hold slight gains on Tuesday after consumer spending in April shows its best gain since August 2009.
The agreement will hand the Dublin company a promising pipeline drug to treat leukemia.
U.S. stock futures are rising slightly Tuesday while European stocks fall as data indicate the eurozone remains in the grip of deflation.
Levi & Korsinsky announces it has commenced an investigation of Jazz Pharmaceuticals plc ("Jazz Pharmaceuticals" or the "Company") (NASDAQ:JAZZ) concerning possible violations of federal securities laws.
Stocks with insider trader activity include TJX, MKSI and JAZZ
Stocks with insider trader activity include YORW, VRNT and JAZZ
Trade-Ideas LLC identified Jazz Pharmaceuticals (JAZZ) as a "storm the castle" (crossing above the 200-day simple moving average on higher than normal relative volume) candidate
Now that the Allergan-Pfizer merger is off, Allergan CEO Saunders could start shopping again for biotech and smaller pharma companies to fuel his company's growth.
Stocks with insider trader activity include TRC, JAZZ and EA
Cramer says to wait on GW Pharmaceuticals but he likes Ashland's fundamentals.
Cramer says the Federal Reserve took a 'common sense' approach to interest rates by only taking action when needed.
Trade-Ideas LLC identified Jazz Pharmaceuticals (JAZZ) as a "water-logged and getting wetter" (weak stocks crossing below support with today's range greater than 200%) candidate
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.